Current issues in child and adolescent psychopharmacology. Part 2: Anxiety and obsessive–compulsive disorders, autism, Tourette’s and schizophrenia

Part 1 of this two-part consideration of child and adolescent psychopharmacology focused on attention–deficit hyperactivity disorder (ADHD), depression and bipolar disorder (Coghill, 2003). This second paper concentrates on current pharmacological approaches to the treatment of anxiety disorders, obsessive–compulsive disorders, autism, Tourette syndrome and schizophrenia. The aim is to describe some recent advances in child and adolescent psychopharmacology in a format that will be of practical benefit to child and adolescent psychiatrists and will also highlight gaps in knowledge.